How can we improve the management of individuals with attention deficit hyperactivity disorders and co-occurring cardiometabolic disease?

References

• Cuschieri S, Mamo J. Getting to grips with the obesity epidemic in Europe. SAGE Open Med. 2016;4:2050312116670406. doi: 10.1177/2050312116670406
   Web of Science ®Google Scholar
• Whiting DR, Guariguata L, Weil C, et al. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabet Res Clin Pract. 2011 Dec;94(3):311–321. doi: 10.1016/j.diabres.2011.10.029
   PubMed Web of Science ®Google Scholar
• Rawshani A, Rawshani A, Franzen S, et al. Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2018 Aug 16;379(7):633–644. doi: 10.1056/NEJMoa1800256
   PubMed Web of Science ®Google Scholar
• Riddle MC, Herman WH. The cost of diabetes care-an elephant in the room. Diabetes Care. 2018 May;41(5):929–932. doi: 10.2337/dci18-0012
   PubMed Web of Science ®Google Scholar
• Faraone SV, Banaschewski T, Coghill D, et al. The world Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neurosci Biobehav Rev. 2021 Sep;128:789–818.
   PubMed Web of Science ®Google Scholar
• Nigg JT. Attention-deficit/hyperactivity disorder and adverse health outcomes. Clin Psychol Rev. 2013 Mar;33(2):215–228. doi: 10.1016/j.cpr.2012.11.005
   PubMed Web of Science ®Google Scholar
• Spencer TJ, Faraone SV, Tarko L, et al. Attention-deficit/hyperactivity disorder and adverse health outcomes in adults. J Nerv Ment Dis. 2014 Oct;202(10):725–731. doi: 10.1097/NMD.0000000000000191
   PubMed Web of Science ®Google Scholar
• Garcia-Argibay M, Du Rietz E, Hartman CA, et al. Cardiovascular risk factors in attention-deficit/hyperactivity disorder: a family design study of Swedish conscripts. Int J Methods Psychiatr Res. 2022 Dec;31(4):e1930. doi: 10.1002/mpr.1930
   PubMed Web of Science ®Google Scholar
• Barkley RA. Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2002;63(Suppl 12):10–15.
   PubMed Web of Science ®Google Scholar
• Cortese S, Moreira-Maia CR, St Fleur D, et al. Association between ADHD and obesity: a systematic review and meta-analysis. Am J Psychiatry. 2016 Jan;173(1):34–43. doi: 10.1176/appi.ajp.2015.15020266
   PubMed Web of Science ®Google Scholar
• Chen Q, Hartman CA, Haavik J, et al. Common psychiatric and metabolic comorbidity of adult attention-deficit/hyperactivity disorder: a population-based cross-sectional study. PLoS One. 2018;13(9):e0204516. doi: 10.1371/journal.pone.0204516
   PubMed Web of Science ®Google Scholar
• Garcia-Argibay M, Li L, Du Rietz E, et al. The association between type 2 diabetes and attention- deficit/hyperactivity disorder: a systematic review, meta-analysis, and population-based sibling study. Neurosci Biobehav Rev. 2023 Apr;147:105076.
   PubMed Web of Science ®Google Scholar
• Li L, Yao H, Zhang L, et al. Attention-deficit/hyperactivity disorder is associated with increased risk of cardiovascular diseases: a systematic review and meta-analysis. JCPP Adv. 2023 Sep;3(3):e12158. doi: 10.1002/jcv2.12158
   PubMedGoogle Scholar
• Li L, Chang Z, Sun J, et al. Attention-deficit/hyperactivity disorder as a risk factor for cardiovascular diseases: a nationwide population-based cohort study. World Psychiatry. 2022 Oct;21(3):452–459. doi: 10.1002/wps.21020
   PubMed Web of Science ®Google Scholar
• Chen Q, Hartman CA, Kuja-Halkola R, et al. Attention-deficit/hyperactivity disorder and clinically diagnosed obesity in adolescence and young adulthood: a register-based study in Sweden. Psychol Med. 2019 Aug;49(11):1841–1849. doi: 10.1017/S0033291718002532
   PubMed Web of Science ®Google Scholar
• Du Rietz E, Brikell I, Butwicka A, et al. Mapping phenotypic and aetiological associations between ADHD and physical conditions in adulthood in Sweden: a genetically informed register study. Lancet Psychiatry. 2021 Sep;8(9):774–783. doi: 10.1016/S2215-0366(21)00171-1
   PubMedGoogle Scholar
• Demontis D, Walters RK, Martin J, et al. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nature Genet. 2019 Jan;51(1):63–75. doi: 10.1038/s41588-018-0269-7
   PubMed Web of Science ®Google Scholar
• Leppert B, Riglin L, Wootton RE, et al. The effect of attention deficit/hyperactivity disorder on physical health outcomes: a 2-sample mendelian randomization study. Am J Epidemiol. 2021 Jun 1;190(6):1047–1055. doi: 10.1093/aje/kwaa273
   PubMed Web of Science ®Google Scholar
• Garcia-Argibay M, du Rietz E, Lu Y, et al. The role of ADHD genetic risk in mid-to-late life somatic health conditions. Transl Psychiatry. 2022 Apr 11;12(1):152. doi: 10.1038/s41398-022-01919-9
   PubMed Web of Science ®Google Scholar
• Baranova A, Chandhoke V, Cao H, et al. Shared genetics and bidirectional causal relationships between type 2 diabetes and attention-deficit/hyperactivity disorder. Gen Psychiatr. 2023;36(2):e100996. doi: 10.1136/gpsych-2022-100996
   PubMed Web of Science ®Google Scholar
• Cortese S, Castellanos FX. The relationship between ADHD and obesity: implications for therapy. Expert Rev Neurotherapeutics. 2014 May;14(5):473–479. doi: 10.1586/14737175.2014.904748
   PubMed Web of Science ®Google Scholar
• Mocanu V, Tavakoli I, MacDonald A, et al. The impact of ADHD on outcomes following bariatric surgery: a systematic review and meta-analysis. Obes Surg. 2019 Apr;29(4):1403–1409. doi: 10.1007/s11695-019-03735-5
   PubMed Web of Science ®Google Scholar
• Stenberg E, Larsson H, Marsk R, et al. Association between attention deficit hyperactivity disorder and outcomes after metabolic and bariatric surgery: a nationwide propensity-matched cohort study. Surg Obes Relat Dis. 2023 Feb;19(2):92–100. doi: 10.1016/j.soard.2022.10.028
   PubMed Web of Science ®Google Scholar
• Chang Z, Ghirardi L, Quinn PD, et al. Risks and benefits of attention-deficit/Hyperactivity disorder medication on behavioral and neuropsychiatric outcomes: a qualitative review of pharmacoepidemiology studies using linked prescription databases. Biol Psychiatry. 2019 Sep 1;86(5):335–343. doi: 10.1016/j.biopsych.2019.04.009
   PubMed Web of Science ®Google Scholar
• Nissen SE. ADHD drugs and cardiovascular risk. N Engl J Med. 2006 Apr 6;354(14):1445–1448. doi: 10.1056/NEJMp068049
   PubMed Web of Science ®Google Scholar
• Mick E, McManus DD, Goldberg RJ. Meta-analysis of increased heart rate and blood pressure associated with CNS stimulant treatment of ADHD in adults. Eur Neuropsychopharmacol. 2013 Jun;23(6):534–541. doi: 10.1016/j.euroneuro.2012.06.011
   PubMed Web of Science ®Google Scholar
• Zhang L, Yao H, Li L, et al. Risk of cardiovascular diseases associated with medications used in attention-deficit/Hyperactivity disorder: a systematic review and meta-analysis. JAMA Netw Open. 2022 Nov 1;5(11):e2243597. doi: 10.1001/jamanetworkopen.2022.43597
   PubMed Web of Science ®Google Scholar
• Cortese S, Adamo N, Del Giovane C, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018 Sep;5(9):727–738. doi: 10.1016/S2215-0366(18)30269-4
   PubMed Web of Science ®Google Scholar
• Kyriacou DN, Lewis RJ. Confounding by indication in clinical research. JAMA. 2016 Nov 1;316(17):1818–1819. doi: 10.1001/jama.2016.16435
   PubMed Web of Science ®Google Scholar
• Denyer H, Ramos-Quiroga JA, Folarin A, et al. ADHD remote technology study of cardiometabolic risk factors and medication adherence (ART-CARMA): a multi-centre prospective cohort study protocol. BMC Psychiatry. 2022 Dec 20;22(1):813. doi: 10.1186/s12888-022-04429-6
   PubMed Web of Science ®Google Scholar
• Cooney MT, Dudina AL, Graham IM. Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians. J Am Coll Cardiol. 2009 Sep 29;54(14):1209–1227. doi: 10.1016/j.jacc.2009.07.020
   PubMed Web of Science ®Google Scholar
• Bernardini F, Attademo L, Cleary SD, et al. Risk prediction models in Psychiatry: toward a New frontier for the prevention of mental illnesses. J Clin Psychiatry. 2017 May;78(5):572–583. doi: 10.4088/JCP.15r10003
   PubMed Web of Science ®Google Scholar
• Dobrosavljevic M, Fazel S, Du Rietz E, et al. Risk prediction model for cardiovascular diseases in adults initiating pharmacological treatment for attention-deficit/hyperactivity disorder. Evid Based Ment Health. 2022 Nov;25(4):185–190. doi: 10.1136/ebmental-2022-300492
   PubMed Web of Science ®Google Scholar